Real-World Effectiveness and Satisfaction with Risankizumab for the Treatment of Psoriatic Arthritis in Biologic-Naïve Patients: A Population Survey in the United States and Europe.

Rheumatol Ther · 2025 · PMC12638470 · PMID 41128765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Time on RZB therapy for TJC resolution and fatigue appears to suggest a positive trend in the proportion of patients achieving clinical resolutions/improvements.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.